Cargando…
Transgenic mice for in vivo epigenome editing with CRISPR-based systems
CRISPR-Cas9 technologies have dramatically increased the ease of targeting DNA sequences in the genomes of living systems. Fusion of chromatin-modifying domains to the nuclease-deactivated dCas9 has enabled targeted epigenome editing in both cultured cells and animal models. However, delivering larg...
Autores principales: | Gemberling, Matthew P., Siklenka, Keith, Rodriguez, Erica, Tonn-Eisinger, Katherine R., Barrera, Alejandro, Liu, Fang, Kantor, Ariel, Li, Liqing, Cigliola, Valentina, Hazlett, Mariah F., Williams, Courtney A., Bartelt, Luke C., Madigan, Victoria J., Bodle, Josephine C., Daniels, Heather, Rouse, Douglas C., Hilton, Isaac B., Asokan, Aravind, Ciofani, Maria, Poss, Kenneth D., Reddy, Timothy E., West, Anne E., Gersbach, Charles A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349887/ https://www.ncbi.nlm.nih.gov/pubmed/34341582 http://dx.doi.org/10.1038/s41592-021-01207-2 |
Ejemplares similares
-
RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
por: Thakore, Pratiksha I., et al.
Publicado: (2018) -
Nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program in zebrafish
por: Gemberling, Matthew, et al.
Publicado: (2015) -
Building bridges, not walls: spinal cord regeneration in zebrafish
por: Cigliola, Valentina, et al.
Publicado: (2020) -
Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014) -
Long-term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy
por: Nelson, Christopher E., et al.
Publicado: (2019)